June 29, 2017 Clinical Research/Diagn. Lab Top-10 Life Science Tools

Illumina Announces FDA-approved Next-Generation Sequencing Cancer Companion Diagnostic Test Kit

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) today announced its Extended RAS Panel, an FDA-approved next-generation sequencing (NGS) kit that meets the newly published guidelines for evaluation of colorectal cancer from the American Society for Clinical Pathology (ASCP), the College of American Pathologists (CAP), the Association for Molecular Pathology (AMP), and the American Society of Clinical Oncology... Read more

June 28, 2017 Clinical Research/Diagn.

GROUNDBREAKING MULTI-CENTER CLINICAL TRIAL CONFIRMS LOW-DOSE ASPIRIN THERAPY REDUCES RATE OF PRE-TERM PREECLAMPSIA

16th FMF World Congress in Fetal Medicine, Ljubljana, Slovenia – June 28, 2017 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the publication of the Fetal Medicine Foundation’s (FMF’s) Project “ASPRE”study results in The New England Journal of Medicine.  These compelling findings revealed that administering low-dose aspirin (150... Read more

June 23, 2017 Clinical Research/Diagn. PR/Corporate Product Launch

Roche presents new data from GALLIUM study reinforcing clinical benefit of Gazyva/Gazyvaro in people with previously untreated follicular lymphoma

Basel, 23 June 2017 Roche presents new data from GALLIUM study reinforcing clinical benefit of Gazyva/Gazyvaro in people with previously untreated follicular lymphoma Longer follow-up showed sustained benefit in progression-free survival of Gazyva/Gazyvaro-based treatment over MabThera/Rituxan-based treatment regardless of chemotherapy regimens  People with follicular lymphoma who received Gazyva/Gazyvaro-based treatment reported improvement in health-related quality of... Read more

June 22, 2017 Clinical Research/Diagn. M&A, Partnerships

DiaSorin and QIAGEN sign collaboration to expand liaison test menu through adoption of select QIAGEN assays

June 22, 2017 – Saluggia, Italy; Hilden, Germany, and Germantown, Maryland – DiaSorin (FTSE Italy Mid Cap: DIA) and QIAGEN (NASDAQ: QGEN; Frankfurt Stock Exchange: QIA) announced today a new collaboration to develop new tests for DiaSorin’s LIAISON family of analyzers based on a review and selection process involving QIAGEN’s assay technologies. The adoption of... Read more

June 22, 2017 Clinical Research/Diagn.

French Health-system approves reimbursement of QIAGEN’s QuantiFERON latent TB test

Gold-standard test for latent tuberculosis infection will be covered by national health insurance Hilden, Germany, and Paris, France, June 22, 2017 – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that France’s Ministry of Health and Social Affairs has approved reimbursement by the national health insurance system for QIAGEN’s QuantiFERON-TB® Gold Plus (QFT-Plus®)... Read more

June 21, 2017 Clinical Research/Diagn. M&A, Partnerships

Seegene Signed MOU with a Mexico Government Agriculture Agency for Collaborative Development of Non-human MDx Assay

MOU signed between Mexico SAGARPA’s INIFAP and Seegene for collaborative product development and clinical study: (from middle to left) INIFAP’s bovine TB Director Dr. Ferando Otero, Head of Seegene Institute of Life Sciences Dr. Nackmoon … SEOUL, South Korea, June 21, 2017 /PRNewswire/ — Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies headquartered... Read more

June 20, 2017 Atomic Spectroscopy Chromatography Clinical Research/Diagn. Lab Top-10 Mass Spectrometry

High-Sensitivity Simultaneous Analysis of Chiral Amino Acids in 10 Minutes without Derivatization Release of the LC/MS/MS Method Package for D/L Amino Acids Contributing to Various Fields Such as Fermented Foods, Clinical and Antiaging Research

The 20 amino acids that form the structure of proteins exist as mirror image optical isomers: the D-amino acids (D-form) and the L-amino acids (L-form) (chiral amino acids)*1). The L-form of amino acids exists in large quantities in foods and in the body as the structural elements of proteins and as nutritional sources. As food... Read more

June 13, 2017 Clinical Research/Diagn.

Bio-Rad Announces FDA Clearance of its BioPlex 2200 Syphilis Total & RPR Assay, a Novel Syphilis Testing Method

HERCULES, Calif. — June 12, 2017 — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global provider of life science research and clinical diagnostic products, today announced it has received U.S. Food and Drug Administration (FDA) clearance for its BioPlex® 2200 Syphilis Total & RPR assay, a novel one-step universal testing method to aid in the diagnosis of... Read more